Yoshinobu Komai

Author PubWeight™ 18.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol 2007 2.15
2 Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor. Int J Clin Oncol 2007 1.38
3 Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 2008 1.24
4 Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol 2009 1.11
5 Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011 1.07
6 Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol 2013 1.01
7 Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 2012 1.00
8 Obstinate cough as a sole presenting symptom of non-metastatic renal cell carcinoma. Int J Urol 2007 0.98
9 A novel technique to prevent postradical retropubic prostatectomy inguinal hernia: the processus vaginalis transection method. Urology 2009 0.95
10 Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin. BJU Int 2012 0.94
11 Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report. Jpn J Clin Oncol 2012 0.92
12 Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases. Int J Urol 2008 0.86
13 Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer. Int J Urol 2008 0.84
14 Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus. Int J Urol 2008 0.83
15 Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol Int 2015 0.81
16 [Primary adenocarcinoma of the female urethra treated by multimodal therapy]. Hinyokika Kiyo 2009 0.80
17 First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma. Urology 2013 0.80
18 Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer. Urology 2008 0.78
19 Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method. BJU Int 2014 0.78
20 Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection. Jpn J Clin Oncol 2009 0.78
21 Analysis of a Surgical Treatment for Persistent Urorectal Fistulas after Radical Cancer Surgery: A Comparison of Prostate Cancer and Rectal Cancer. Urol Int 2017 0.75
22 [A case of primary leiomyosarcoma of the spermatic cord]. Nihon Hinyokika Gakkai Zasshi 2004 0.75
23 Development of prognostic model for predicting survival after retrograde placement of ureteral stent in advanced gastrointestinal cancer patients and its evaluation by decision curve analysis. Minerva Urol Nefrol 2015 0.75